Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial.
Saved in:
| Title: | Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial. |
|---|---|
| Authors: | Khanna S; Mayo Clinic, Rochester, 200 First St SW, Rochester, MN 55905, USA., Yoho D; Mid-Atlantic Permanente Medical Group, Springfield, VA, USA., Van Handel D; MNGI Digestive Health, Minneapolis, MN, USA., Clark BJ; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Awad T; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Guthmueller B; Ferring Pharmaceuticals, Inc., Parsippany, NJ, USA., Armandi D; Ferring Pharmaceuticals A/S, Copenhagen, Denmark., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Safdar N; University of Wisconsin, Madison, WI, USA., Baggott B; Cleveland Clinic, Cleveland, OH, USA., Simon K; Om Research, Camarillo, CA, USA., Feuerstadt P; PACT Gastroenterology Center, Yale School of Medicine, Hamden, CT, USA. |
| Source: | Therapeutic advances in gastroenterology [Ther Adv Gastroenterol] 2025 Nov 09; Vol. 18, pp. 17562848251396744. Date of Electronic Publication: 2025 Nov 09 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: England NLM ID: 101478893 Publication Model: eCollection Cited Medium: Print ISSN: 1756-283X (Print) Linking ISSN: 1756283X NLM ISO Abbreviation: Ther Adv Gastroenterol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-283X |
|---|---|
| DOI: | 10.1177/17562848251396744 |
